Status:
COMPLETED
Absorption and Distribution of Glucosamine and Chondroitin
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Osteoarthritis
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The purpose of this study is to examine the way the dietary supplements glucosamine and chondroitin are absorbed and distributed throughout the body.
Detailed Description
Osteoarthritis is the most common musculoskeletal disease in the world. While predisposing conditions have been identified, the actual cause of osteoarthritis remains unknown. Traditional treatments, ...
Eligibility Criteria
Inclusion
- Able to walk
Exclusion
- Allergy to glucosamine, chondroitin, or shellfish
- Liver or kidney disease
- Diabetes mellitus
- Concurrent use of other complementary or alternative therapies
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00086229
Start Date
April 1 2004
End Date
January 1 2006
Last Update
August 18 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah Health Sciences Center
Salt Lake City, Utah, United States, 84132